Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 23,125 | 21,897 | 23,482 | 13,483 | 15,147 |
| Cost of Goods | 10,826 | 9,441 | 12,183 | 13,935 | 6,251 |
| Gross Profit | 12,299 | 12,456 | 11,299 | -452 | 8,896 |
| Operating Expenses | 24,419 | 40,596 | 35,554 | 26,149 | 14,722 |
| Operating Income | -11,294 | -27,699 | -24,072 | -25,666 | -5,575 |
| Other Income | -257 | -259 | 5,333 | 206 | -3,950 |
| Pre-tax Income | -11,551 | -27,958 | -18,739 | -25,460 | -9,525 |
| Income Tax | -3 | -107 | N/A | 0 | 0 |
| Net Income Continuous | -11,548 | -27,851 | -18,998 | -25,460 | -9,525 |
| Net Income | $-11,548 | $-27,851 | $-18,998 | $-25,460 | $-9,525 |
| EPS Basic Total Ops | -8.74 | -21.76 | -20.00 | -28.20 | -14.40 |
| EPS Basic Continuous Ops | -8.74 | -21.76 | -20.04 | -28.15 | -14.34 |
| EPS Diluted Total Ops | -8.74 | -21.76 | -20.00 | -28.20 | -14.40 |
| EPS Diluted Continuous Ops | -8.74 | -21.76 | -20.04 | -28.15 | -14.34 |
| EBITDA(a) | $-8,784 | $-5,730 | $-12,369 | $-19,424 | $-3,658 |